Can a simple blood test spot cancer early? Here’s what we know

For those who’re feeling worn out or have immediately misplaced some weight, your physician would possibly ship you for a blood check.

Blood exams are a standard approach health-care professionals detect, diagnose, and monitor a spread of medical circumstances.

However can they assist us detect extra severe circumstances resembling most cancers? Let’s dive into the analysis.

How do blood exams work?

Blood exams are a method used within the subject of pathology, which is the examine of the character and causes of illness.

Blood exams
assess what cells, proteins, and molecules are current within the blood. Well being-care professionals use them to observe issues like organ well being, vitamin ranges, immune system operate, and the presence of some infections.

To check for
anaemia, for instance, you’d take a blood check and depend the variety of crimson blood cells in that blood pattern. One other instance is blood sugar testing, which is used to measure the glucose ranges of a affected person with diabetes.

What can blood exams inform us about most cancers?

At present, we are able to’t reliably diagnose most cancers utilizing a blood check. One main motive is it’s typically tough to differentiate between most cancers cells and regular, wholesome cells. That is very true with regards to early-stage tumours.

However blood check outcomes may give us clues about whether or not sure cancers are current within the physique. So how do they do that?

1. By revealing abnormalities in your blood

Blood cancers will typically trigger clear adjustments within the quantity and kinds of cells within the bloodstream. We will measure these adjustments utilizing a
full blood depend, also referred to as a “full blood examination”.

This kind of blood check counts all of the various kinds of cells current within the blood: crimson blood cells, white blood cells, platelets, and extra.
Blood cancers come up when your physique produces an irregular quantity of any sort of blood cell. White blood cells, which combat an infection, are the most typical instance. So a excessive variety of a number of of those cell sorts might recommend the presence of a blood most cancers.

However full blood counts aren’t sufficient to make a conclusive analysis of blood most cancers. We have to carry out different exams to substantiate whether or not the issue is a most cancers or a unique illness. These exams might embrace a biopsy or imaging strategies resembling an MRI, CT scan, or X-ray.

2. By figuring out “tumour markers”

We will additionally use blood exams to detect particular proteins which most cancers cells typically produce in larger numbers. These proteins are generally known as “tumour markers”.

One instance of a tumour marker is
prostate-specific antigen. This antigen is a protein made completely by the prostate gland. A wholesome male can have solely a small quantity of prostate-specific antigen in his blood. In distinction, a male with prostate most cancers will typically produce abnormally excessive ranges of this antigen. On this approach, the prostate-specific antigen can function a “marker” of prostate most cancers.

There are various
totally different tumour markers used to determine totally different cancers. Nonetheless, measuring tumour markers is just not a foolproof answer. It’s because they are often influenced by different elements. For instance, an harm to or irritation of the prostate gland may trigger prostate-specific antigen ranges to extend. So your physician might carry out extra exams to substantiate if an individual has most cancers.

3. By finding rogue cells

For different kinds of most cancers, blood exams can search for
circulating tumour cells. Circulating tumour cells are produced when most cancers cells break off from the unique tumour after which enter the bloodstream. This normally solely occurs when a most cancers reaches a extra superior stage and is
metastatic, that means it has unfold to different components of the physique.

However the sort of check is normally prognostic, fairly than diagnostic. This implies we are able to solely use it to observe the development of a most cancers which has already been recognized. So if a blood check does determine circulating tumour cells, it’s best to conduct extra exams earlier than continuing with therapy.

So, are we near making a cancer-detecting blood check?

Sadly, we’re but to discover a strategy to detect most cancers with a single blood check. It’s a really tough job, however researchers are making progress.

Circulating tumour DNA is a present subject of curiosity. These DNA molecules have mutations which distinguish them from wholesome cells and may give details about the most cancers they got here from.

In a single
2025 trial, Australian researchers measured the quantity of circulating tumour DNA in 441 folks with colon most cancers to find out which sufferers would reply to chemotherapy. One other
examine from 2025 used circulating tumour DNA to observe how 940 sufferers with lung most cancers responded to totally different remedies.

One check did declare to efficiently use circulating tumour DNA to detect greater than 50 kinds of early-stage most cancers. It’s generally known as the “Galleri check” and was first trialled within the UK in 2021. Nonetheless, some consultants have since
raised considerations in regards to the check’s effectiveness.

Researchers are additionally exploring different methods of utilizing blood exams. In a single
2025 examine, Australian researchers tailored an current check to make use of blood as a substitute of tissue samples to
determine identified markers of ovarian most cancers.

One other Australian
examine from 2025 investigated whether or not molecules aside from proteins may function most cancers markers. It discovered sure fat in blood can point out if a affected person with superior prostate most cancers will
reply to therapy.

So, it appears to be like like we’re nonetheless some time away from making a cancer-detecting blood check. However with a while, effort, and strong analysis, it might be a chance.

John (Eddie) La Marca, Senior Analysis Officer, Blood Cells and Blood Most cancers, WEHI (Walter and Eliza Corridor Institute of Medical Analysis) ;
Cameron Lewis, Clinician Scientist, WEHI (Walter and Eliza Corridor Institute of Medical Analysis) , and
Sarah Diepstraten, Senior Analysis Officer, Blood Cells and Blood Most cancers Division, WEHI (Walter and Eliza Corridor Institute of Medical Analysis)

This text is republished from
The Dialog below a Inventive Commons license. Learn the
authentic article.